Attached files

file filename
8-K - FORM 8-K - AMERICAN VANGUARD CORPd8k.htm
EX-99.2 - PRESS RELEASE OF AMERICAN VANGUARD CORPORATION DATED MARCH 11, 2011 - AMERICAN VANGUARD CORPdex992.htm

Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS FOURTH QUARTER & FULL YEAR 2010 RESULTS

Newport Beach, CA – March 8, 2011 – American Vanguard Corporation (NYSE:AVD), today announced financial results for the fourth quarter and full year ended December 31, 2010.

Fiscal 2010 Fourth Quarter Financial Highlights – versus Fiscal 2009 Fourth Quarter:

 

   

Net sales were $62.5 million compared to $50.8 million.

   

Net income (loss) was $4.0 million compared to ($8.6)* million.

   

Earnings (loss) per diluted share were $0.14 versus ($0.32)*.

Fiscal 2010 Financial Highlights – versus Fiscal 2009 Results:

 

   

Net sales were $229.6 compared to $209.3 million.

   

Net income (loss) was $11.0 compared to ($5.8) million*.

   

Earnings (loss) per diluted share were $0.40 versus ($0.21)*.

* Net Income and Earnings per share results for the Fourth Quarter and Full Year 2009 reflect the inclusion of a one-time, non-cash charge of $13.5 million taken to adjust the inventories of American Vanguard at December 31, 2009.

Eric Wintemute, President and CEO of American Vanguard, stated: “Our 2010 performance reflects a number of improving trends in our business. After coping with the very conservative purchasing patterns of growers and distributors during 2009, we have seen demand for our products improve steadily throughout 2010. Replenishment of depleted channel inventories, expansion of cotton acreage in the U.S., and an increase in our sales & marketing effectiveness has fueled growth in most of our major product categories.

“Compared to the prior year period, sales grew 23% in the fourth quarter and 10% for the full year. Gross profit margins for the year improved to 39% as we focused our sales initiatives on a higher margin product mix and adjusted our manufacturing operations to respond more efficiently to changes in customer demand. We achieved improved overall financial performance despite lost sales and profit opportunities in our PCNB product line attributable to a stop-sale order. On this subject, as you will read in our 10-K filing, the Company continues to work with the EPA to resolve this matter.”

Mr. Wintemute continued: “During the year we pursued the acquisition of several prominent branded products that have excellent market positions, solid profit margins and were available at terms that met our investment criteria. Our purchase of the cotton defoliant Def®, the insecticides Mocap®, Nemacur®, Aztec® (U.S. bag business) and the soil fumigant Basamid® represents the


largest series of product acquisitions in our history. These new product lines should serve to double our international business, improve our factory utilization over the next three years, and contribute positively to our financial profitability. Integration of these new products has begun and will be one of the most important objectives of 2011.

“In 2011 we see many encouraging prospects. The rising level of cotton and corn commodity prices should encourage growers to expand acreage and purchase inputs that enhance yields, which favors American Vanguard’s strong market positions in those two crops. The increasing demand for residential & commercial pest protection from numerous insects, particularly the expanding bed-bug epidemic, has stimulated strong interest in our unique Nuvan® product line. Our intensified efforts to develop and introduce new products should begin to bear fruit later this year with the expected registration and commercial introduction of our SmartBlock® potato sprout inhibitor.”

Mr. Wintemute concluded: “American Vanguard is well positioned to benefit from improving market conditions for crop protection and pest control solutions. Our organization is evolving to take full advantage of these opportunities with the hiring of talented new employees who possess the set of skills that the Company needs to succeed. Management remains committed to the financial discipline and debt reduction that has strengthened our balance sheet and we will prudently utilize our recently secured five-year credit facility to facilitate steady, sustainable growth.”

Conference Call

Eric Wintemute, President & CEO and David T. Johnson, VP & CFO, will conduct a conference call focusing on the financial results at 12:00 pm ET / 9:00 am PT on Tuesday, March 8, 2011. Interested parties may participate in the call by dialing (201) 689-8349 – please call in 10 minutes before the call is scheduled to begin, and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

Company Contact:

American Vanguard Corporation

William A. Kuser, Director of Investor Relations

(949) 260-1200

williamk@amvac-chemical.com

 

Investor Representative

The Equity Group Inc.

www.theequitygroup.com

Lena Cati

Lcati@equityny.com

(212) 836-9611


CONSOLIDATED BALANCE SHEETS

December 31, 2010 and 2009

(Dollars in thousands, except share and per share data)

 

     2010     2009  

Assets

    

Current assets:

    

Cash

   $ 1,158      $ 383   

Receivables:

    

Trade, net of allowance for doubtful accounts of $447 and $636, respectively

     33,833        40,681   

Other

     263        382   
                
     34,096        41,063   
                

Inventories

     74,054        72,512   

Prepaid expenses

     2,622        2,143   

Income taxes receivable

     6,715        4,132   
                

Total current assets

     118,645        120,233   

Property, plant and equipment, net

     40,541        39,196   

Intangible assets

     115,249        86,973   

Other assets

     7,364        8,866   
                
   $ 281,799      $ 255,268   
                

Liabilities and Stockholders’ Equity

    

Current liabilities:

    

Current installments of long-term debt

   $ 8,427      $ 8,528   

Accounts payable

     13,961        11,958   

Deferred Revenue

     5,568        —     

Accrued program costs

     18,596        27,188   

Accrued expenses and other payables

     4,634        3,762   
                

Total current liabilities

     51,186        51,436   

Long-term debt, excluding current installments

     53,712        45,432   

Other long-term liabilities

     3        192   

Deferred income taxes

     10,461        5,121   
                

Total liabilities

     115,362        102,181   
                

Commitments and contingent liabilities Stockholders’ equity:

    

Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued

     —          —     

Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 29,735,928 shares in 2010 and 29,575,562 shares in 2009

     2,974        2,958   

Additional paid-in capital

     43,403        41,529   

Accumulated other comprehensive loss

     (448     (1,743

Retained earnings

     123,661        113,496   
                
     169,590        156,240   

Less treasury stock, at cost, 2,260,996 shares in both 2010 and 2009

     (3,153     (3,153
                

Total stockholders’ equity

     166,437        153,087   
                
   $ 281,799      $ 255,268   
                


CONSOLIDATED STATEMENTS OF OPERATIONS

Three months and twelve months ended December 31, 2010 and 2009

(Dollars in thousands, except per share data)

 

     For the three months ended
December 31
    For the twelve months ended
December 31
 
             2010                     2009                     2010                     2009          

Net sales

   $ 62,480      $ 50,836      $ 229,620      $ 209,329   

Cost of sales

     36,931        46,749        140,538        148,903   
                                

Gross profit

     25,549        4,087        89,082        60,426   

Operating expenses

     20,111        17,185        69,891        66,755   
                                

Operating income (loss)

     5,438        (13,098     19,191        (6,329

Interest expense

     691        631        3,171        3,253   

Interest capitalized

     (56     (6     (154     (44
                                

Income (loss) before provision for income taxes

     4,803        (13,723     16,174        (9,538

Income taxes (benefit) expense

     900        (5,142     5,190        (3,749
                                

Net income (loss)

   $ 3,903      $ (8,581   $ 10,984      $ (5,789
                                

Earnings (loss) per common share—basic

   $ 0.14      $ (0.32   $ 0.40      $ (0.21
                                

Earnings (loss) per common share—assuming dilution

   $ 0.14      $ (0.32   $ 0.40      $ (0.21
                                

Weighted average shares outstanding—basic

     27,452        27,241        27,385        27,120   
                                

Weighted average shares outstanding—assuming dilution

     27,682        27,241        27,652        27,120   
                                


CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31, 2010 and 2009

(Dollars in thousands)

 

     2010     2009  

Increase (decrease) in cash

    

Cash flows from operating activities:

    

Net income (loss)

   $ 10,984      $ (5,789

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

    

Depreciation and amortization

     9,917        9,050   

Amortization of intangibles

     4,464        4,437   

Stock-based compensation expense related to stock options, employee stock purchases and directors’ fees

     1,122        1,223   

Deferred income taxes

     5,342        (778

Changes in assets and liabilities associated with operations:

    

Decrease in net receivables

     6,967        10,905   

(Increase) decrease in inventories

     (1,542     18,114   

Increase in income tax receivable

     (2,583     (4,132

Increase in prepaid expenses and other assets

     (2,235     (2,898

Increase/(decrease) in accounts payable

     3,095        (2,828

Increase in deferred revenue

     5,568        —     

(Decrease) increase in other payables and accrued expenses

     (7,909     4,647   
                

Net cash provided by operating activities

     33,190        31,951   
                

Cash flows from investing activities:

    

Capital expenditures

     (8,004     (4,322

Acquisitions of intangible assets

     (32,677     —     
                

Net cash used in investing activities

     (40,681     (4,322
                

Cash flows from financing activities:

    

Net (repayments) borrowings under line of credit agreement

     4,700        (21,900

Payments on long-term debt

     (8,107     (4,106

Increase (decrease) in other notes payable

     11,586        (2,438

Proceeds from the issuance of common stock

     768        1,470   

Payment of cash dividends

     (819     (1,611
                

Net cash provided by (used in) financing activities

     8,128        (28,585
                

Net increase (decrease) in cash

     637        (956

Cash at beginning of year

     383        1,229   

Effect of exchange rate changes on cash

     138        110   
                

Cash at end of year

   $ 1,158      $ 383   
                

Supplemental cash flow information:

    

Cash paid during the year for:

    

Interest

   $ 3,661      $ 3,279   
                

Income taxes

   $ 2,452      $ 3,361